DiaplasininAlternative Names: PAI-749
Latest Information Update: 14 Aug 2009
At a glance
- Originator Wyeth
- Class Antithrombotics; Indoles; Small molecules
- Mechanism of Action Plasminogen activator inhibitor-1 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 06 Jun 2004 Phase-I clinical trials in Thrombosis in USA (PO)
- 31 Dec 2003 Preclinical trials in Thrombosis in USA (PO)